Effects of pulsatile delivery of basal growth hormone on lipolysis in humans

American Journal of Physiology - Endocrinology and Metabolism

Volumn 271, Issue 1 34-1, 1996, Pages

  Cersosimo, E ^a,b   Danou, F ^a   Persson, M ^a   Miles, J M ^a  

^a MAYO CLINIC   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

fat metabolism; free fatty acids; oscillatory secretion; palmitate; somatotropin

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; PALMITIC ACID; RECOMBINANT GROWTH HORMONE;

ADULT; AMPLITUDE MODULATION; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DELIVERY SYSTEM; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LIPOLYSIS; MALE; NORMAL HUMAN; PERIODICITY; PRIORITY JOURNAL; PULSATILE FLOW; RANDOMIZED CONTROLLED TRIAL;

EID: 0029812622     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1996.271.1.e123     Document Type: Article

References (22)

1. Abraham, G. E. Radioassay Systems in Clinical Endocrinology. New York: Dekker, 1981.
2. Belchetz, P., T. Plat, Y. Nakai, E. Keogh, and E. Knobil. Hypophyseal responses to continuous and intermittent delivery of hypothalamic gonadotrophin-releasing hormone. Science Wash. DC 202: 631-633, 1978.
3. Cryer, P., and W. Daughaday. Diabetic ketosis - serial plasma growth hormone concentrations during therapy. Diabetes 19: 519-523, 1970.
4. Faber, O., C. Binder, J. Markussen, L. Heiding, V. Naithani, H. Kuzuya, P. Blix, D. Horwitz, and A. Rubenstein. Characterization of seven C-peptide antisera. Diabetes 27, Suppl 1: 170-177, 1978.
5. Ferranini, E., E. Barrett, E. Bevilacqua, and R. DeFronzo. Effect of fatty acids on glucose production and utilization in man. J. Clin. Invest. 72: 1737-1747, 1983.
6. Goodner, C., B. Walike, D. Koerker, J. Ensinck, A. Brown, E. Chideckerl, J. Palmer, and L. Kalnasy. Insulin, glucagon, and glucose exhibit synchronous sustained oscillations in fasting monkeys. Science Wash. DC 195: 177-179, 1977.
7. Gyr, K., C. Berlinger, E. Kohler, U. Trautzl, U. Keller, and S. Bloom. Circulating somatostatin: physiological regulator of pancreatic function? J. Clin. Invest. 79: 1595-1600, 1987.
8. Herbert, V., K. Lau, C. Gottlieb, and S. Bleicher. Cooled charcoal immunoassay of insulin. J. Clin. Endocrinol. Metab. 25: 1375-1384, 1965.
9. Jensen, M., M. Caruso, V. Heiling, and J. Miles. Insulin regulation of lipolysis in non-diabetic and IDDM subjects. Diabetes 38: 1595-1601, 1989.
10. Jensen, M., V. Heiling, and J. Miles. Measurement of non-steady-state free fatty acid turnover. Am. J. Physiol. 258 (Endocrinol. Metab. 21): E103-E108, 1990.
11. Jensen, M., V. Heiling, and J. Miles. Effects of glucagon on free fatty acid metabolism in humans. J. Clin. Endocrinol Metab. 72: 308-315, 1991.
12. Jensen, M., P. Rogers, M. Ellman, and J. Miles. Choice of infusion-sampling mode for tracer studies of free fatty acid metabolism. Am. J. Physiol. 254 (Endocrinol. Metab. 17): E562-E565, 1988.
13. Keller, U., H. Schnell, J. Girard, and W. Stauffacher. Effect of physiological elevation of plasma growth hormone levels on ketone body kinetics and lipolysis in normal and acutely insulin-deficient man. Diabetologia 26: 103-108, 1984.
14. Marks, V., N. Howorth, and F. Greenwood. Plasma growth hormone levels in chronic starvation in man. Nature Lond. 208. 686-687, 1965.
15. Matthews D., B. Naylor, R. Jones, G. Ward, and R. Turner. Pulsatile insulin has greater hypoglycemic effect than continuous delivery. Diabetes 32: 617-621, 1983.
16. Miles, J., M. Ellman, K. McClean, and M. Jensen. Validation of a new method for determination of free fatty acid turnover. Am. J. Physiol. 252 (Endocrinol. Metab. 15): E431-E438, 1987.
17. Moller, N., P. C. Butler, M. A. Antsiferov, and K. G. M. Alberti. Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man. Diabetologia 32: 105-110, 1989.
18. Paolisso, G., A. Scheen, A. Albert, and P. Lefebvre. Effects of pulsatile delivery of insulin and glucagon in humans. Am. J. Physiol. 257 (Endocrinol. Metab. 20): E686-E696, 1989.
19. Quabbe, H. J., E. Schilling, and H. Helge. Pattern of growth hormone secretion during 24-hour fast in normal adults. J. Clin Endocrinol. Metab. 26: 1173-1177, 1966.
20. Shaw, J., and R. Wolfe. The integrated effect of adrenergic blockade on glucose, fatty acid and glycerol kinetics: responses in the basal and during hormonal control with somatostatin-hormonal infusion. J. Surg. Res. 42: 257-272, 1987.
21. Ulloa-Aguirre, A., R. Blizzard, E. Garcia-Rubi, A. Rogol, K. Link, C. Christie, M. Johnson, and J. Veldhuis. Testosterone and oxandrolone, a nonaromatizable androgen, specifically amplify the mass and the rate of growth hormone (GH) secreted per burst without altering GH secretory burst duration or frequency of the GH half-life. J. Clin. Endocrinol. Metab. 71: 846-854, 1978.
22. Winer, L., M. Shaw, and G. Bauman. Basal plasma growth hormone levels in man: new evidence for rhythmicity of growth hormone secretion. J. Clin. Endocrinol. Metab. 70: 1678-1686, 1990.